Neuphoria Therapeutics Inc. (NEUP)

NASDAQ: NEUP · Real-Time Price · USD

3.760

-0.010 (-0.27%)

At close: Aug 28, 2026, 4:00 PM EDT

3.770

+0.010 (0.27%)

After-hours: Aug 28, 2026, 4:27 PM EDT

Neuphoria Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Cash & Equivalents	19.44	14.21	12.61	12.1	23.13	21.37
Cash & Short-Term Investments	19.44	14.21	12.61	12.1	23.13	21.37
Cash Growth	14.06%	12.71%	4.17%	-47.66%	8.23%	576.06%
Accounts Receivable	-	-	-	-	-	0.14
Other Receivables	1.61	0.01	0.13	0.43	4.67	0.7
Receivables	1.61	0.01	0.13	0.43	4.67	0.85
Prepaid Expenses	0.61	0.74	0.46	0.8	1.01	0.65
Restricted Cash	-	0.08	-	-	-	0.33
Total Current Assets	21.66	15.04	13.19	13.33	28.81	23.19
Property, Plant & Equipment	-	0.11	0.22	0.33	0.46	0.65
Goodwill	8.84	8.64	8.69	8.69	8.87	9.3
Other Intangible Assets	4.31	4.8	5.47	6.13	6.78	7.46
Other Long-Term Assets	-	-	0.08	0.08	0.08	0.09
Total Assets	34.81	28.59	27.65	28.56	45	40.68

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Accounts Payable	0.63	1.15	2.24	1.44	1.07	0.77
Accrued Expenses	0.49	2.88	1.39	1.19	1.13	0.87
Short-Term Debt	0.03	0.03	0.03	-	-	-
Current Portion of Leases	-	0.12	0.12	0.11	0.11	0.13
Other Current Liabilities	0.36	0.04	0.04	-	-	-
Total Current Liabilities	1.51	4.22	3.83	2.74	2.31	1.77
Long-Term Leases	-	-	0.12	0.24	0.37	0.52
Pension & Post-Retirement Benefits	-	-	-	-	0.01	0.01
Long-Term Deferred Tax Liabilities	0.39	0.5	0.96	1.1	1.24	1.38
Other Long-Term Liabilities	3.48	4.87	5.25	2.47	1.86	1.32
Total Liabilities	5.39	9.59	10.16	6.55	5.79	5

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Common Stock	0	0	0	-	149.99	142.59
Additional Paid-In Capital	218.39	200.19	198.48	187.55	-	-
Retained Earnings	-186.89	-178.35	-177.98	-162.48	-119.41	-115.49
Comprehensive Income & Other	-2.07	-2.85	-3.01	-3.06	8.63	8.58
Shareholders' Equity	29.42	19	17.49	22.01	39.21	35.69
Total Liabilities & Equity	34.81	28.59	27.65	28.56	45	40.68

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Total Debt	0.03	0.15	0.27	0.35	0.48	0.65
Net Cash (Debt)	19.41	14.06	12.34	11.75	22.65	20.72
Net Cash Growth	15.02%	13.99%	4.99%	-48.12%	9.32%	-
Net Cash Per Share	5.51	8.66	14.82	0.01	0.02	0.03
Filing Date Shares Outstanding	5.4	2.36	3,118	1,469	1,353	1,008
Total Common Shares Outstanding	5.38	1.98	2,385	1,469	1,353	1,008
Working Capital	20.14	10.82	9.36	10.59	26.49	21.42
Book Value Per Share	5.47	9.60	0.01	0.01	0.03	0.04
Tangible Book Value	16.27	5.56	3.33	7.19	23.57	18.93
Tangible Book Value Per Share	3.03	2.81	0.00	0.00	0.02	0.02
Machinery	-	-	-	-	-	0.08

SEC Filings: 10-K · 10-Q